A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge
- Status
- COMPLETED
- Phase
- PHASE2
CemiplimAb Survivorship Epidemiology
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
- Status
- COMPLETED
- Phase
- PHASE4
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Early Alirocumab to Reduce LDL-C in Myocardial Infarction
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Adult Participants With Advanced PD-L1 Positive Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
- Status
- WITHDRAWN
- Phase
- PHASE2
Long Term Safety Study of PRALUENT
- Status
- TERMINATED
- Phase
- PHASE4
Investigating Dupilumab's Effect in Asthma by Genotype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee
- Status
- COMPLETED
- Phase
- PHASE2
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
- Status
- COMPLETED
- Phase
- PHASE2